Sun Pharma Q2 profit falls 36% YoY to Rs 1,989 crore on exceptional charges.
Context
What happened: Sun Pharma reported a 36% year on year fall in Q2 profit to Rs 1,989 crore, attributed to exceptional charges.
Key numbers: Profit Rs 1,989 crore, down 36% YoY. Revenue from operations Rs 16,199 crore, up 12% from Rs 14,478 crore a year earlier.
Why it matters: Revenue growth was supported by strong performance in the domestic formulations business and emerging markets, even as profit declined on exceptional charges.
What changed
Sun Pharma reported a 36% year on year fall in Q2 profit to Rs 1,989 crore, attributed to exceptional charges.